Axl is required for TGF-β2-induced dormancy of prostate cancer cells in the bone marrow
Open accessAbstract
Disseminated prostate cancer (PCa) cells in the marrow survive for years without evidence of proliferation, while maintaining the capacity to develop into metastatic lesions. These dormant disseminated tumor cells (DTCs) may reside in close proximity to osteoblasts, while expressing high levels of Axl, one of the tyrosine kinase receptors for growth arrest specific 6 (Gas6). Yet how Axl regulates DTC proliferation in marrow remains undefined. Here, we explored the impact of the loss of Axl in PCa cells (PC3 and DU145) on the induction of their dormancy when they are co-cultured with a pre-osteoblastic cell line, MC3T3-E1. MC3T3-E1 cells dramatically decrease the proliferation of PCa cells, however this suppressive effect of osteoblasts is significantly reduced by the reduction of Axl expression in PCa cells. Interestingly, expression of both TGF-β and its receptors were regulated by Axl expression in PCa cells, while specific blockade of TGF-β signaling limited the ability of the osteoblasts to induce dormancy of PCa cells. Finally, we found that both Gas6 and Axl are required for TGF-β2-mediated cell growth suppression. Taken together, these data suggest that a loop between the Gas6/Axl axis and TGF-β2 signaling plays a significant role in the induction of PCa cell dormancy.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
TGF-β2 contributes to metastatic tumor dormancy.
“TGF-β2 was reported to contribute to metastatic tumor dormancy333–335”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [335]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 48 · Cited by 170
- Authors
- Yumoto, K., Eber, M. R., Wang, J., Cackowski, F. C., Decker, A. M., Lee, E., Nobre, A. R., Aguirre-Ghiso, J. A., Jung, Y., & Taichman, R. S.
- Affiliations
- University of Michigan (US)
- Tisch Cancer Institute (US)
- Corresponding author
- Taichman, Russell S.
- ORCID
- Venue
- Scientific Reports
- Published
- 2016-11-07
- Volume
- 6
- Issue
- 1
- Pages
- 36520-36520
- ISSN
- 2045-2322 (ISSN-L)
- PMC
- PMC5098246
- OpenAlex
- W2552831679
- Cited by
- 170
- References
- 48
- Citations by year
- 2026: 13 · 2025: 16 · 2024: 18 · 2023: 17 · 2022: 16 · 2021: 29 · 2020: 21 · 2019: 14 · 2018: 20 · 2017: 3 · 2016: 2 · 2014: 1
- FWCI
- 11.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Scientific Reports (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Defense (CA093900, W81XW-15–1-0413, W81XWH1410403, W81XWH)
- Prostate Cancer Foundation (CA163124, CA093900, CA143055, U54CA143803)
- University of Michigan
- National Cancer Institute (U54CA163124, P01CA093900, CA093900, U01CA143055, U54CA143803, CA163124, CA143055, T32CA009357, R01CA109182)
- National Institute of Dental and Craniofacial Research (T32DE007057)
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Prostate Cancer Treatment and Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- AXL, TGF-β2 signaling, prostate cancer, disseminated tumor cells, tumor dormancy, bone marrow, osteoblasts, Gas6, receptor tyrosine kinase, tumor microenvironment, metastasis, cell proliferation inhibition
- MeSH terms
- Animals, Bone Marrow, Humans, Male, Osteoblasts, Prostate, Prostatic Neoplasms, Signal Transduction, Receptor Protein-Tyrosine Kinases, Intercellular Signaling Peptides and Proteins, Cell Line, Tumor, Cell Proliferation, Mice, Transforming Growth Factor beta2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review